Select Page

Important Disclaimer Buddha Jeans Company Website Terms and Conditions

All contents on the site published under the Creative Commons Attribution 4.0 international license. Disclaimer Buddha Jeans Company

  • The list is a part of Buddha Jeans Company library and published under Creative Commons attribution 4.0 International license
  • I have therefore not any interest of or paid by any party for the opinion and materials published
  • Not paid for
  • Not paid by
  • Read, think and ask questions to the materials including Buddha Jeans Company is in the interest of humanity
  • Be careful and critical to ads or issues regarding our site
  • Ask questions directly
  • Or to third parties including the same open attitude
  • post and pages published included visual contents
  • Eco-Fashion Encyclopedia
  • Denim-Encyclopedia
  • Diagrams library
  • Graphics is free to us

Denim Encyclopedia by Kenneth L is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at https://buddhajeans.com/eco-and-denim-dictionaries/denim-dictionary-contents-a-z/.
Permissions beyond the scope of this license may be available at https://buddhajeans.com/disclaimer/.
Creative Commons License
Diagram Library by Kenneth L is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at https://buddhajeans.com/eco-and-denim-dictionaries/diagrams-overview-a-z-eco-fashion-dictionary/.
Permissions beyond the scope of this license may be available at https://buddhajeans.com/disclaimer/.
Creative Commons License
Eco-Fashion Encyclopedia by Kenneth L is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at https://buddhajeans.com/eco-and-denim-dictionaries/eco-fashion-dictionary-a-z/.
Permissions beyond the scope of this license may be available at https://buddhajeans.com/disclaimer/.

The series of posts Coronavirus


The source list following the posts published, other issues, book lists and variously governmental organisations and publication 1997-2018
The series of posts Coronavirus

Reflection on the impact of COVID-19 on economic growth vs ecological limits

Understanding the catastrophe risk economy, war on biological threats

War on germs the catastrophic catalyser of economic growth

Why sustainable development fails, and the poorest pays the price.

A brand with a cause Levi Strauss Co Robert D. Haas achievements of long-term thinking

The discontent of short-term thinking of manufacture outsourcing part two


Book-list

  • Emerging Epidemics Management and Control, editor Prakash S. Bisen and Ruchika Raghuvanshi
  • Defense Research Development Establishment, Defense Research Development Organization
  • Ministry of Defense, Government of India Gwalior, India. Published 2013 by John Wiley & Sons, Inc.
  • An Epidemiological Odyssey Dr George Pollock The Evolution of Communicable Disease Control. Published 2012 by Springer Science + Business Media B.V. 2012
  • Pandemic influenza: emergency planning and community preparedness/editor, Jeffrey R. Ryan
  • Published 2008 by CRS Press DNA Viruses Methods and Protocols Edited by Paul M. Lieberman The Wistar Institute, Philadelphia, Published 2005 Humana Press Inc.
  • Encyclopedia of Molecular Biology Volumes 1 – 4. Published 1999 John Wiley & Sons, Inc.
  • Viruses and human disease by James H. Strauss and Ellen G. Strauss Division of Biology
  • California Institute of Technology Pasadena, California San Diego. Published 2002 by Academic Press
  • The science and application of microbial genomics. Published 2013 by the National Academy of Sciences
  • Respiratory Genetics Edited by Edwin K. Silverman MD, PhD Channing Laboratory and Division of Pulmonary and Critical Care Medicine. Published 2005 by 2005 by Hodder Education
  • Life as Surplus Biotechnology and Capitalism in the Neoliberal Era by Melinda Cooper. Published 2008 by the University of Washington Press
  • Foundations of microbiology published editors Talaro, Kathleen P. and I. Chess, Barry. Published 2012 by Microbiology with diseases by body system Robert W. Bauman
  • Plagues and Epidemics Infected Spaces Past and Present Edited by D. Ann Herring and Alan C. Swedlund. Published 2010 Berg Publishing
  • Epidemiology insights Edited by Maria de Lourdes Ribeiro de Souza da Cunha., Published 2012 by Intech.
  • The possibilities of knowledge by Quassim Cassam. Published 2008 by Oxford University Press

RAND

The Global Threat of New and Reemerging Infectious Diseases Reconciling U.S. National Security and Public Health Policy by Jennifer Brower, Peter Chalk 2003
Download books.
WEBSITE RAND.ORG


US DOC post 9/11
MEDICAL COUNTERMEASURES GOV
Enhancing the Nation’s PUBLIC HEALTH SECURITY and emergency preparedness by facilitating communication on innovative products and solutions between federal agencies and public stakeholders.
WEBSITE MEDICAL COUNTER-MEASURES GOV


HOMELAND SECURITY PUBLIC LAW OCT 2003 PDF 1-21 page
WEBSITE Gov public law homeland security


OFFICE OF THE SECRETARY AND EXECUTIVE MANAGEMENT
For necessary expenses of the Office of the Secretary of Homeland Security, as authorized by section 102 of the Homeland Security Act of 2002 (6 U.S.C. 112), and executive management of the Department of Homeland Security, as authorized by law,: Provided, That not to exceed shall be for allocation within the Department for official reception and representation expenses as the Secretary may determine.
OFFICE OF THE UNDER SECRETARY FOR MANAGEMENT
For necessary expenses of the Office of the Under Secretary for Management and Administration, as authorized by sections 701–705 of the Homeland Security Act of 2002 (6 U.S.C. 341– 345),: Provided, that of the total amount provided, shall remain available until expended solely for the alteration and improvement of facilities and for relocation costs necessary for the interim housing of the Department’s headquarters’ operations and organizations collocated therewith.
DEPARTMENT-WIDE TECHNOLOGY INVESTMENTS
For development and acquisition of information technology equipment, software, services, and related activities for the Department of Homeland Security, and for the costs of conversion to narrowband communications, including the cost for operation of the land mobile radio legacy systems, 3, to remain available until expended: Provided, that none of the funds appropriated shall be used to support or supplement the appropriations provided for the United States Visitor and Immigrant Status Indicator Technology project or the Automated Commercial Environment. Department of Homeland Security Appropriations Act, 2004. Oct. 1, 2003 [H.R. 2555] VerDate 11-MAY-2000 06:59 Oct 07, 2003 Jkt 029139 PO 00090 Frm 00001 Fmt 6580 Sfmt 6581
E:\PUBLAW\PUBL090.108 BILLW PsN: PUBL090 117 STAT. 1138 PUBLIC LAW 108–90—OCT. 1, 2003 OFFICE OF INSPECTOR GENERAL
For necessary expenses of the Office of Inspector General in carrying out the provisions of the Inspector General Act of 1978 (5 U.S.C. App.), of which not to exceed may be used for certain confidential operational expenses, including the payment of informants, to be expended at the direction of the Inspector General.
TITLE II—SECURITY, ENFORCEMENT, AND INVESTIGATIONS OFFICE OF THE UNDER SECRETARY FOR BORDER AND TRANSPORTATION SECURITY SALARIES AND EXPENSES
For necessary expenses of the Office of the Under Secretary for Border and Transportation Security, as authorized by subtitle A, title IV, of the Homeland Security Act of 2002 (6 U.S.C. 201 et seq.)
UNITED STATES VISITOR AND IMMIGRANT STATUS INDICATOR TECHNOLOGY
For necessary expenses for the development of the United States Visitor and Immigrant Status Indicator Technology project, as authorized by section 110 of the Illegal Immigration Reform and Immigration Responsibility Act of 1996 (8 U.S.C. 1221 note), to remain available until expended: Provided, That none of the funds appropriated under this heading may be obligated for the United States Visitor and Immigrant Status Indicator Technology project until the Committees on Appropriations of the Senate and the House of Representatives receive and approve a plan for expenditure prepared by the Secretary of Homeland Security that: (1) meets the capital planning and investment control review requirements established by the Office of Management and Budget, including Circular A–11, part 3; (2) complies with the Department of Homeland Security enterprise information systems architecture; (3) complies with the acquisition rules, requirements, guidelines, and systems acquisition management practices of the Federal Government; (4) is reviewed and approved by the Department of Homeland Security and the Office of Management and Budget; and (5) is reviewed by the General Accounting Office.
CUSTOMS AND BORDER PROTECTION SALARIES AND EXPENSES
For necessary expenses for enforcement of laws relating to border security, immigration, customs, and agricultural inspections and regulatory activities related to plant and animal imports; acquisition, lease, maintenance and operation of aircraft; purchase and lease of up to 4,500 (3,935 for replacement only) police-type vehicles; and contracting with individuals for personal services abroad;
which shall be derived from the Harbor Maintenance Trust Fund for administrative expenses related to the collection of the Harbor Maintenance Fee pursuant to Public Law 103–182 and not with-standing section 1511(e)(1) of VerDate
11-MAY-2000 06:59 Oct 07, 2003, Jkt 029139 PO 00090 Frm 00002 Fmt 6580 Sfmt 6581 E:\PUBLAW\PUBL090.108 BILLW PsN: PUBL090 PUBLIC LAW 108–90—OCT. 1, 2003 1


WEBPAGE BIO SHIELD ACT 2004

Critical Mission for Bio defence mission
On July 21, 2004, President George W. Bush signed the Project BioShield Act of 2004 (Project BioShield) into law as part of a broader strategy to defend America against the threat of weapons of mass destruction. The purpose of Project BioShield is to accelerate the research, development, purchase, and availability of effective medical countermeasures against biological, chemical, radiological, and nuclear (CBRN) agents. HHS provides Congress with an annual report on its progress in the implementation of
Project BioShield.
Governmental information BioShield


HOMELAND SECURITY PRESIDENTIAL DIRECTIVE—1 ORGANIZATION AND OPERATION OF THE HOMELAND SECURITY COUNCIL OCTOBER 29, 2001

WEBPAGE doc PDF


HOMELAND SECURITY LAW OCT 2003
Public law
Public Law 108–90 108th Congress Act 200
WEBPAGE doc PDF


WEBSITE OVERVIEW ALL DEPT AND TERMS WITHIN THE US COUNTER- MESURES GOV
Name glossary all terms of departments and inks
WEBPAGE doc


Site Glossary
TERM SHORT TERM LONG WEBLINK
A
ADS, Analytical Decision Support
AIG, Anthrax Immune Globulin
AMCG, Office of Acquisition Management, Contracts, & Grants
AMIC, Animal Model Interagency Committee
Arenavirus, The Arenaviridae are a family of viruses whose members are generally associated with rodent-transmitted diseases in humans. Each virus usually is associated with a particular rodent host species in which it is maintained.
Animal Efficacy Rule, The FDA Animal Efficacy Rule (also known as Animal Rule) applies to the development/testing of drugs/biologicals to reduce or prevent serious/life-threatening conditions caused by exposure to lethal /permanently disabling toxic agent (chemical, biological, radiological, or nuclear substances), where human efficacy trials are not feasible or ethical.
ARS, Acute Radiation Syndrome; also known as radiation poisoning, radiation sickness or radiation toxicity, is a collection of health effects which present within 24 hours of exposure to high amounts of ionizing radiation.
ASPR, Assistant Secretary for Preparedness and Response
B
BAA, Broad Agency Announcements
BARDA, Biomedical Advanced Research and Development Authority
BPN, Business Partner Network
BSA, Broad Spectrum Antimicrobials
C
CAP, Concept Acceleration Program
CBMS, Chemical Biological Medical Systems
CBRN, Chemical, Biological, Radiological and Nuclear Threats
CBRND, Chemical, Biological, Radiological and Nuclear Threats Defense
CDC, Centres for Disease Control
CDER, Center for Drug Evaluation and Research
CFR, Code of Federal Regulations
CIADM, Centers for Innovation in Advanced Development and Manufacturing
CLIA, Clinical Laboratory Improvement Amendment
CSN, Clinical Studies Network
D
DARPA, Defense Advanced Research Projects Agency
DCEG, Division of Cancer Epidemiology and Genetics
DCS, Clinical Studies group
DHS, Department of Homeland Security #
DoD, Department of Defense
DSMB, Data Safety Monitoring Board
DTRA, Defense Threat Reduction Agency
E
EID, Emerging Infectious Diseases
EMS, Emergency Medical Services
EUA, Emergency Use Authorization
F
FAR, Federal Acquisition Regulations
FD&C, Federal Food, Drug and Cosmetic Act
FDA, Food and Drug Administration
FedBizOpps, Federal Business Opportunities
FFMN, Fill Finish Manufacturing Network
G
GI, Gastrointestinal
GPE, Government Point-of-Entry
H
HGS, Human Genome Sciences
HHS, U.S. Department of Health and Human Services
HHSAR, Department of Health and Human Services Acquisition Regulation
I
IEDB, Immune Epitope Database
IND, Investigational New Drug
J
JOFOC, Justification for Other than Full and Open Competition
M
MCM, Medical Countermeasures
MCMi, Medical Countermeasures initiative
MMWR, Morbidity and Mortality Weekly Report
N
NARA, National Archives and Records Administration
NBLs, National Biocontainment Laboratories
NCI, National Cancer Institute
NHLBI, National Heart, Lung and Blood Institute
NIAID, National Institute of Allergy and Infectious Diseases
NIH, National Institutes of Health
NINDS, National Institute of Neurological Disorders and Stroke
NSABB, National Science Advisory Board for Bio-Security
O
OEM, Office of Emergency Management
OMB, Office of Management and Budget
OPP, Office of Policy and Planning
P
PAHPA, The Pandemic and All-Hazards Preparedness Act
PBS, Project BioShield
PDTs, Product Development Tools
PEP, Post-Event Prophylactic
PHCM, Public Health Consequence Modeling
PHEMCE, Public Health Emergency Medical Countermeasures Enterprise
PHS, Public Health Service
R
RBLs, Regional Biocontainment Laboratories
RCE, Regional Centers of Excellence
REB, Radiation Epidemiology Branch
RFP, Request for Proposal
RQA, Division of Regulatory and Quality Affairs
RSV, Respiratory Syncytial Virus
RTOR, Request for Task Order Response
S
SAE, Serious Adverse Event
SIP, Strategy and Implementation Plan
SNS, Strategic National Stockpile
SST, Strategic Science and Technology
T
TICs, Toxic Industrial Chemicals
TIMs, Toxic Industrial Materials
TMTI, Transformational Medical Technologies Initiative
TRA, Terrorism Risk Assessment
TRLs, Technology Readiness Levels


Name HOMELAND SECURITY PRESIDENTIAL DIRECTIVE—1 ORGANIZATION AND OPERATION OF THE HOMELAND SECURITY COUNCIL OCTOBER 29, 2001 A.
WEBPAGE doc PDF

Homeland Security Council Securing Americans from terrorist threats or attacks is a critical national security function. It requires extensive coordination across a broad spectrum of Federal, State, and local agencies to reduce the potential for terrorist attacks and to mitigate damage should such an attack occur. The Homeland Security Council (HSC) shall ensure coordination of all homeland security-related activities among executive departments and agencies and promote the effective development and implementation of all homeland security policies. B.

The Homeland Security Council Principals
Committee The HSC Principals Committee (HSC/PC) shall be the senior interagency forum under the HSC for homeland security issues. The HSC/PC is composed of the following members:

The Homeland Security Council Principals *security issues

  • Secretary of the Treasury
  • Secretary of Defense Attorney General
  • Secretary of Health and Human Services
  • Secretary of Transportation
  • Director of the Office Management and Budget
  • Assistant to the President for Homeland Security (who serves as Chairman)
  • Assistant to the President Chief of Staff
  • Director of Central Intelligence
  • Director of the Federal Bureau of Investigation
  • Director of the Federal Emergency Management Agency
  • Assistant to the President
  • Chief of Staff to the Vice President.
  • The Assistant to the President for National Security Affairs shall be invited to attend all meetings of the HSC/PC.

The following people shall be invited to HSC/PC meetings when issues pertaining to their responsibilities and expertise are discussed:

People list invited homeland security meeting *security issues.

  • the Secretary of State
  • the Secretary of the Interior
  • the Secretary of Agriculture the Secretary of Commerce
  • the Secretary of Labor
  • the Secretary of Energy
  • the Secretary of Veterans Affairs
  • the Administrator of the Environmental Protection Agency
  • Deputy National Security Advisor for Combating Terrorism.
  • The Counsel to the President shall be consulted regarding the agenda of HSC/PC meetings and shall attend any meeting when in consultation with the
  • Assistant to the President for Homeland Security, the

Counsel deems it appropriate.
The Deputy Director of the Office of Homeland Security shall serve as Executive Secretary of the HSC/PC. Other 2 heads of departments and agencies and senior officials shall be invited, when appropriate. The HSC/PC shall meet at the call of the Assistant to the President for Homeland Security, in consultation with the regular attendees of the HSC/PC. The Assistant to the President for Homeland Security shall determine the agenda, in consultation with the regular attendees, and shall ensure that all necessary papers are prepared. When global terrorism with domestic implications is on the agenda of the HSC/PC, the Assistant to the President for Homeland Security and the Assistant to the President for National Security Affairs shall perform these tasks in concert.
Name CBRN
WEBPAGE doc
https://www.medicalcountermeasures.gov/glossary.aspx#CBRN
Name BARDA HOMEPAGE
WEBPAGE doc

HHS GOVERNMENTAL
U.S. Department of Health & Human Services | Assistant Secretary for Preparedness and Response | Biomedical Advanced Research and Development Authority
Partner site

WEBPAGE doc
DRIVE EZ-BAA (BAA-20-100-SOL-0002)
Pursuant to FAR 35.016(c), the official posting of the broad agency announcement is available on beta.sam.gov and can be found here: BAA-20-100-SOL-0002. The announcement as it is posted on beta.sam.gov serves as the official Governmentwide point of entry (GPE). The content below is information directly from the GPE and is provided here for ease of reference only. In the event of any conflict or inconsistency between information on the GPE and the below information, the information found on the GPE shall control.


AOI’s Currently Accepting Submissions:
Unless otherwise noted below, open AOI’s are accepting submissions throughout the EZ-BAA open period which ends 03 February 2023, 1700 HRS ET. BARDA reserves the right to revise the status of submission periods for any of the AOI’s or the EZ-BAA itself. Any change to open periods for submissions will be posted in the form of an amendment / special instruction to the EZ-BAA.

AOI #1: ENACT (Early Notification to Act, Control and Treat) (ENACT@hhs.gov)
AOI #2: Infection Severity & Solving Sepsis (SolvingSepsis@hhs.gov)
AOI #5: ReDIRECT (Repurposing Drugs In Response to Chemical Threats) (chemrepo@hhs.gov)
AOI #6: Beyond the Needle (BeyondTheNeedle@hhs.gov)
span data-contrast=”auto”>Closed AOIs:
AOI #3: Other Disruptive Innovations
AOI #4: COVID-19
AOI #4.1-A Molecular Diagnostic Assay for SARS-CoV-2 virus on existing FDA-cleared platform
AOI #4.1-B Point-of-Care Diagnostic Assay for detection of SARS-CoV-2 virus
AOI #4.1-C: Diagnostic Assay for detection of COVID-19 disease
AOI #4.1-D: Remote Patient Monitoring/Remote Diagnostic Tools
AOI #4.1-E: Pediatric Diagnostic Tools for Severe COVID-19 Disease and MIS-C
AOI #4.2: Nonclinical Model Development and Screening for SARS-CoV-2 virus
AOI #4.3: Alternative Routes of Administration (AROA) for Vaccines [Re-established as AOI#6: Beyond the Needle]
AOI #4.4: Advanced Manufacturing Technologies

BARDA DRIVe EZ-BAA Document
Originally Posted February 3rd, 2020 – This Easy Broad Agency Announcement (EZ-BAA) sets forth areas of interest (AOIs) for the Division of Research, Innovation, and Ventures (DRIVe) in the Office of Biomedical Advanced Research and Development Authority (BARDA), issued under paragraph 6.102(d)(2)(i) of the Federal Acquisition Regulation (FAR). Abstract submissions selected for the award are the result of full and open competition and in full compliance with 41 U.S.C. § 3301.
DRIVe EZ-BAA.pdf
We partner with companies and teams offering solutions to a broad range of national health security threats. DRIVe partnering approaches vary depending on the project. DRIVe has two main solicitations, our EZ-BAA for awards under €616.01K and our BAA Special Instructions for larger projects.


Name FEAR ACT GOVERNMENTAL
On May 15, 2002, Congress enacted the Notification and Federal Employee Antidiscrimination and Retaliation Act of 2002 (No FEAR Act). One purpose of the Act is torequire that federal agencies be accountable for violations of anti-discrimination and whistleblower protection laws” (Public Law 107-174). Notification requirements of the No FEAR Act require that federal agencies provide the following information to their employees, former employees and applicants for employment, in order to inform them of their rights and protections available under federal anti-discrimination and whistleblower protection laws.

For further information regarding the No FEAR Act regulations, please refer to 5 CFR Part 724, as well as the Equal Employment Opportunity (EEO) Office. Additional information regarding federal anti-discrimination, whistleblower protection and retaliation laws can be found, as applicable, on the

WEBSITE No fear Act

Whistleblower protection laws
A federal employee with authority to take, direct others to take, recommend or approve any personnel action must not use the authority to take or fail to take, or threaten to take or fail to take, a personnel action against an employee or applicant because of disclosure of information by that individual that is reasonably believed to evidence:

  • violations of law
  • rule or regulation
  • gross mismanagement
  • gross waste of funds
  • abuse of authority
  • substantial and specific danger to public health or safety, unless disclosure of such information is specifically required by Executive Order to be kept secret, in the interest of national defence or the conduct of foreign affairs. Retaliation against an employee or applicant for making a protected disclosure is prohibited by 5 U.S.C. § 2302(b)(8). If you believe that you have been the victim of whistleblower retaliation, you may file a written complaint (Form OSC-11) by mail or online:

U.S. Office of Special Counsel
1730 M Street NW, Suite 218
Washington, DC, 200364505

Online through the Office of Special Counsel website. Retaliation for engaging in protected activity
The FEC cannot retaliate against an employee or applicant because that individual exercises his or her rights under any of the federal anti-discrimination or whistleblower protection laws listed above.
If you believe that you are the victim of retaliation for engaging in protected activity, you must follow, as appropriate, the procedures described in the anti-discrimination laws and whistleblower protection laws sections, or, if applicable, the administrative or negotiated grievance procedures in order to pursue any legal remedy.

Disciplinary actions
Under the existing laws, the FEC retains the right, where appropriate, to discipline a federal employee for conduct that is inconsistent with federal anti-discrimination and whistleblower protection laws up to and including removal. If the U.S. Office of Special Counsel has initiated an investigation under 5 U.S.C. § 1214, however, according to 5 U.S.C. § 1214(f), agencies must seek approval from the Special Counsel to discipline employees for, among other activities, engaging in prohibited retaliation. Nothing in the No FEAR Act alters existing laws or permits the FEC to take unfounded disciplinary action against a federal employee or to violate the procedural rights of a federal employee who has been accused of discrimination.

Existing rights unchanged
Pursuant to section 205 of the No FEAR Act, neither the Act nor this notice create, expands or reduces any rights otherwise available to any employee, former employee or applicant under the laws of the United States, including the provisions of law specified in 5 U.S.C. § 2302(d).


END

%d bloggers like this: